The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer
- PMID: 15865588
- DOI: 10.5694/j.1326-5377.2005.tb06784.x
The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer
Abstract
Objective: To evaluate the frequency and management of anaemia in Australian adults with solid and haematological malignancies.
Design: 6-month observational, prospective, multicentre study.
Participants: 694 patients recruited from outpatient oncology clinics in 24 hospitals in five Australian states between 9 April 2001 and 31 July 2001.
Main outcome measures: Frequency of anaemia (haemoglobin [Hb] level < 120 g/L) at enrolment and over ensuing 6 months, by tumour type, disease status and cancer treatment; anaemia treatment and "trigger" Hb level for this treatment.
Results: Participants had median age 60 years, and 61% were women. Prevalence of anaemia at enrolment was 35% (199/562), with 78% of these 199 having mild anaemia (Hb, 100-119 g/L). Frequency of anaemia (either present at enrolment or developing during the study) was 57% overall (323/566), and varied with tumour type, from 49% (lymphoma/myeloma) to 85% (urogenital cancer). Patients who received radiotherapy either in combination or concomitant with chemotherapy were more likely to have anaemia (73%) than those receiving chemotherapy alone (58%) (P = 0.004). Of all chemotherapy patients not anaemic at enrolment, 23% developed anaemia by the second monthly follow-up. Independent predictors for anaemia in chemotherapy patients were low baseline Hb level (odds ratio [OR], 5.4; 95% CI, 2.7-10.9) and use of platinum chemotherapeutic agents (OR, 4.8; 95% CI, 2.1-11.4) (P < 0.001). Anaemia was treated in 41% of patients with anaemia at enrolment--by transfusion (36%), iron (5%) and erythropoietic agents (2%). Frequency of anaemia treatment varied between tumour types, from 19% (breast cancer) to 60% (leukaemia). The mean "trigger Hb" for initiating transfusion was 95 g/L.
Conclusions: Anaemia is prevalent among Australian patients with cancer managed in hospital oncology units. Its management varies between tumour types. Many patients do not receive treatment for their anaemia.
Similar articles
-
High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).Support Care Cancer. 2012 Jan;20(1):23-8. doi: 10.1007/s00520-010-1045-0. Epub 2010 Nov 25. Support Care Cancer. 2012. PMID: 21107613
-
Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.Med Oncol. 1998 Aug;15 Suppl 1:S19-28. Med Oncol. 1998. PMID: 9785333 Review.
-
[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)].Bull Cancer. 2007 Oct;94(10):907-14. Bull Cancer. 2007. PMID: 17964985 French.
-
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.Eur J Cancer. 2004 Oct;40(15):2293-306. doi: 10.1016/j.ejca.2004.06.019. Eur J Cancer. 2004. PMID: 15454256
-
Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.Drugs. 2007;67(2):175-94. doi: 10.2165/00003495-200767020-00002. Drugs. 2007. PMID: 17284083 Review.
Cited by
-
Profiling chemotherapy-associated myelotoxicity among Chinese gastric cancer population receiving cytotoxic conventional regimens: epidemiological features, timing, predictors and clinical impacts.J Cancer. 2017 Aug 18;8(13):2614-2625. doi: 10.7150/jca.17847. eCollection 2017. J Cancer. 2017. PMID: 28900499 Free PMC article.
-
Treatment strategies in elderly patients with multiple myeloma: current status.Drugs Aging. 2007;24(10):829-50. doi: 10.2165/00002512-200724100-00004. Drugs Aging. 2007. PMID: 17896832 Review.
-
Prevalence of Anemia and Associated Factors among Newly Diagnosed Patients with Solid Malignancy at Tikur Anbessa Specialized Hospital, Radiotherapy Center, Addis Ababa, Ethiopia.Adv Hematol. 2019 Oct 20;2019:8279789. doi: 10.1155/2019/8279789. eCollection 2019. Adv Hematol. 2019. PMID: 31781226 Free PMC article.
-
Iron Deficiency Anemia Coexists with Cancer Related Anemia and Adversely Impacts Quality of Life.PLoS One. 2016 Sep 28;11(9):e0163817. doi: 10.1371/journal.pone.0163817. eCollection 2016. PLoS One. 2016. PMID: 27682226 Free PMC article.
-
High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).Support Care Cancer. 2012 Jan;20(1):23-8. doi: 10.1007/s00520-010-1045-0. Epub 2010 Nov 25. Support Care Cancer. 2012. PMID: 21107613
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous